Skip to main content

Cogstate (AU:CGS) — Company Overview, News & Financial Data

Cogstate logo
CGSCogstate
Cogstate primary media
Company profile

Cogstate

About

Explore Australia companies

Cogstate (ASX:CGS) is focused on the development and commercialisation of digital cognitive assessment tools. The company's products are used by researchers and clinicians around the world to assess cognitive function in a variety of settings, including clinical trials, clinical practice, and academic research. Cogstate's operations are focused on the commercialization of its digital cognitive assessment tools in the United States, Europe, and other markets. The company also provides a range of services, such as data analysis and consulting services.

Snapshot

Public AUOwnership
1999Year founded
212Employees
Victoria, AustraliaHead office
Loading Map...
Global footprint

Operations

All Locations
Australia

Products and/or services of Cogstate

  • Cognitive assessment tools: Cogstate offers a range of cognitive assessment tools that can be used to measure a variety of cognitive functions, including attention, memory, processing speed, and executive function.
  • Clinical trials services: Cogstate offers a range of clinical trials services to help pharmaceutical companies and other organisations measure the cognitive effects of their drugs and treatments.
  • Research services: Cogstate offers a range of research services to help researchers study cognition and brain health.
  • Data analytics services: Cogstate offers a range of data analytics services to help organisations analyse their cognitive data and identify trends and patterns.
  • Consulting services: Cogstate offers a range of consulting services to help organisations develop and implement cognitive assessment programs.
  • Educational services: Cogstate offers a range of educational services to help people learn about cognitive function and brain health.

Cogstate executive team

  • Mr. Bradley John O'Connor B.Bus, C.A.CEO, MD & Executive Director
  • Mr. Darren WatsonChief Financial Officer
  • Dr. Pamela Ventola Ph.D.Chief Science Officer
  • Ms. Rachel ColiteExecutive VP of Clinical Trials
  • Prof. Paul Maruff BBSc (Hons), Ph.D.Founder & Chief Innovation Officer
  • Ms. Kristi Geddes L.L.B.General Counsel, Joint Company Secretary & Director
  • Mr. Kenneth BillardChief Commercial Officer
  • Dr. Kaycee Sink M.D.Chief Medical Officer
  • Mr. David James Franks BEc, C.A., F Fin, J.P.Joint Company Secretary